Genomic Aberrations in Human Hepatocellular Carcinomas of Differing Etiologies
We sought to assess whether genetic abnormalities in hepatocellular carcinoma differed in geographic locations associated with different risk factors. Comparative genomic hybridization (CGH) was applied to the genome-wide chromosomal analysis in 83 tumor samples from four different geographic origin...
Gespeichert in:
Veröffentlicht in: | Clinical cancer research 2000-10, Vol.6 (10), p.4000-4009 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | We
sought to assess whether genetic abnormalities in hepatocellular
carcinoma differed in geographic locations associated with different
risk factors. Comparative genomic hybridization (CGH) was applied to
the genome-wide chromosomal analysis in 83 tumor samples from four
different geographic origins. Samples were obtained from regions that
differed in aflatoxin exposure: China (Hong Kong with low aflatoxin
exposure and Shanghai with moderate aflatoxin exposure), Japan, and the
United States (negligible aflatoxin exposure). Cases from Hong Kong and
Shanghai were all hepatitis B virus (HBV) related, those from Japan
were hepatitis C virus related, and those from the United States were
HBV negative. In parallel, the mutational pattern of the whole
p53 gene (exons 1–11) was also investigated in these
cases. CGH revealed a complex pattern of chromosomal gains and losses,
with the commonest aberration in each geographic location being
chromosome 1q copy number gain (38–60%). Shanghai cases displayed the
highest number of total aberrations per sample, with significant copy
losses on 4q (75%), 8p (70%), and 16q (65%). Hepatitis C
virus-related samples from Japan had a characteristically high
incidence of 11q13 gain. p53 mutation(s) was detected in
23% of Hong Kong cases, 40% of Shanghai, 31% of Japan, but only 6%
of the United States cases. The “aflatoxin-associated” codon 249
mutation was, however, identified only in samples from China (13% Hong
Kong and 20% Shanghai). This finding, together with the highly
aberrant pattern of genetic changes detected in the Shanghai series, is
suggestive of the genotoxic effects of aflatoxin being more broadly
based. It is also likely that there is a synergistic effect of HBV
infection and high aflatoxin exposure in promoting hepatocellular
carcinoma development. It appears from our CGH study that individual
risk factors are indeed associated with distinct genetic aberrations,
although changes in 1q gain appear common to all. |
---|---|
ISSN: | 1078-0432 1557-3265 |